Clinical Trials Logo

Prolymphocyctic Leukemia clinical trials

View clinical trials related to Prolymphocyctic Leukemia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01217749 Completed - Clinical trials for Small Lymphocytic Lymphoma

Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL

PCYC-1109-CA
Start date: December 2010
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the efficacy and safety of a fixed-dose, daily regimen of orally administered PCI-32765 combined with ofatumumab in subjects with relapsed/refractory CLL/SLL and related diseases